59 results on '"Nobili, Valerio"'
Search Results
2. The Contribution of the Adipose Tissue-Liver Axis in Pediatric Patients with Nonalcoholic Fatty Liver Disease after Laparoscopic Sleeve Gastrectomy
3. Comparison between non-alcoholic fatty liver disease screening guidelines in children and adolescents
4. Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis
5. Prevalence of prediabetes and diabetes in children and adolescents with biopsy-proven non-alcoholic fatty liver disease
6. The Role of Genetic Predisposition, Programing During Fetal Life, Family Conditions, and Post-natal Diet in the Development of Pediatric Fatty Liver Disease
7. Evaluations of Lifestyle, Dietary, and Pharmacologic Treatments for Pediatric Nonalcoholic Fatty Liver Disease: A Systematic Review
8. A review of the pathogenic and therapeutic role of nutrition in pediatric nonalcoholic fatty liver disease
9. Pancreatic disorders in children: New clues on the horizon
10. Laparoscopic Sleeve Gastrectomy Improves Nonalcoholic Fatty Liver Disease–Related Liver Damage in Adolescents by Reshaping Cellular Interactions and Hepatic Adipocytokine Production
11. Nonalcoholic Fatty Liver Disease in Italian Children with Down Syndrome: Prevalence and Correlation with Obesity-Related Features
12. Good adherence to the Mediterranean diet reduces the risk for NASH and diabetes in pediatric patients with obesity: The results of an Italian Study
13. Long-term challenges and perspectives of pre-adolescent liver disease
14. The Benefit of Sleeve Gastrectomy in Obese Adolescents on Nonalcoholic Steatohepatitis and Hepatic Fibrosis
15. Reduced lysosomal acid lipase activity – A potential role in the pathogenesis of non alcoholic fatty liver disease in pediatric patients
16. A “systems medicine” approach to the study of non-alcoholic fatty liver disease
17. High concentrations of H2O2 trigger hypertrophic cascade and phosphatase and tensin homologue (PTEN) glutathionylation in H9c2 cardiomyocytes
18. Lipid-Induced Hepatocyte-Derived Extracellular Vesicles Regulate Hepatic Stellate Cells via MicroRNA Targeting Peroxisome Proliferator-Activated Receptor-γ
19. Statin use and non-alcoholic steatohepatitis in at risk individuals
20. A non-invasive prediction model for non-alcoholic steatohepatitis in paediatric patients with non-alcoholic fatty liver disease
21. Pediatric non-alcoholic fatty liver disease: Recent advances
22. A practical approach to the child with abnormal liver tests
23. Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity
24. Non-alcoholic fatty liver disease
25. Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: An input for novel therapies
26. Nonalcoholic Fatty Liver in Children and Adolescents: An Overview
27. Non-alcoholic fatty liver disease in children now: Lifestyle changes and pharmacologic treatments
28. Hepatitis B virus infection in children
29. Liver fibrosis in paediatric liver diseases
30. Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease
31. Relationship between portal chronic inflammation and disease severity in paediatric non-alcoholic fatty liver disease
32. A Combination of the Pediatric NAFLD Fibrosis Index and Enhanced Liver Fibrosis Test Identifies Children With Fibrosis
33. Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease
34. Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD)
35. Association between type two diabetes and non-alcoholic fatty liver disease in youth
36. Retinol-Binding Protein 4: A Promising Circulating Marker of Liver Damage in Pediatric Nonalcoholic Fatty Liver Disease
37. Metformin use in children with nonalcoholic fatty liver disease: An open-label, 24-month, observational pilot study
38. Chapter 16 - Obesity and Nonalcoholic Fatty Liver Disease in Children
39. Treatment of Wilson’s disease with zinc from the time of diagnosis in pediatric patients: A single-hospital, 10-year follow-up study
40. Portal hypertension in children
41. The IRGM rs10065172 variant increases the risk for steatosis but not for liver damage progression in Italian obese children
42. Contributors
43. P-255 - Arachidonic acid to docosahexaenoic acid ratio (AA/DHA): a strong clinical outcome predictor in DHA-based nutritional therapy of pediatric NASH
44. Author response re. “Mediterranean diet to prevent/treat nonalcoholic fatty liver disease in children: A promising approach”
45. Chapter 21 - Role of Fatty Liver Disease in Childhood Obesity
46. Clinical observation paper: Fatty liver and metabolic syndrome: is it a burden for the future generations?
47. Safety of ultrasound-guided-percutaneous core needle liver biopsies of pediatric patients: A single center experience
48. Non-alcoholic fatty liver disease and non-alcoholic fatty pancreas disease: A new intriguing association?
49. A single-centre, tertiary-care, Italian registry of celiac disease: Incidence and clinical presentation
50. Juvenile hemochromatosis associated with heterozygosity for novel hemojuvelin mutations and with unknown cofactors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.